» 行業新聞 » China to Balance COVID-19 Fight and Economic Development

中國將平衡應對新冠肺炎 (COVID-19) 疫情和經濟發展

2022-08-22

A medical worker takes a swab sample from a resident for nucleic acid testing in Jilin city, Jilin province, 六月 21, 2022.

China’s fight against the COVID-19 epidemic has entered the stage that stresses striking a balance between disease control and social and economic development, Li Bin, vice-minister of the National Health Commission, said on Saturday.

He said global COVID-19 counts remain high and new mutations are emerging, threatening to trigger more sporadic infections and local outbreaks in China.

Li said China will combine regular disease containment measures with emergency response in virus-hit regions, and make its virus control work more precise, efficient and scientific.

He spoke at the 2022 National Vaccines and Health Conference held in Beijing. The conference will last for a week.

Li added that the mainland has administered over 3.4 billion COVID-19 vaccines and fully vaccinated 89 percent of its total population.

More systematic research is needed on the immunogenicity and immunity persistence of vaccines and their protection effects in the long term. Close attention should also be paid to study emerging variantseffects on existing doses, and preparedness and R&D should be launched to create variant-specific vaccines,” 他說.

同時, he called for sustaining routine vaccination campaigns, and ensuring that the vaccination rate of children eligible for the national immunization program remains above 90 百分.

Shen Hongbin, deputy head of the National Administration of Disease Prevention and Control and director of the Chinese Center for Disease Control and Prevention, said that China has made significant progress in vaccination drives in recent years.

現在, 大約有 80,000 routine vaccination stations. During the peak of COVID-19 vaccination, 關於 216,000 new vaccination facilities were added, leading to a record number of doses delivered in one day at 25 百萬.

The information system for vaccination and monitoring mechanism for adverse effects have also been established and improved in recent years, 他加了.

 

來源: 中國日報

也許你也喜歡

  • 關於我們


    醫療技術公司, 有限公司. 是中國醫療用品的專業製造商, 我們生產和銷售尼龍植絨棉籤, VTM套件, 唾液收集套件和 CHG 拭子 & 塗抹器.

  • 聯繫我們

    地址: 房間 201, 301 和 401 A座10號, 寶龍五路, 同樂社區, 寶龍街, 龍崗區,深圳, 粵, 中國.

    網絡: www.medicoswab.com

    電話號碼: +86 0755-28997664

    電子郵件: info@medicoswab.com